Survival after treatment of rabies with induction of coma

New England Journal of Medicine

Volumn 352, Issue 24, 2005, Pages 2508-2514

  Willoughby Jr , Rodney E ^a,c   Tieves, Kelly S ^a   Hoffman, George M ^a   Ghanayem, Nancy S ^a   Amlie Lefond, Catherine M ^a   Schwabe, Michael J ^a   Chusid, Michael J ^a   Rupprecht, Charles E ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Midwest Athletes Against Childhood Cancer Fund Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; AZELASTINE; BENZODIAZEPINE; DIAZEPAM; HEPARIN; IBUPROFEN; IMMUNOGLOBULIN; INOTROPIC AGENT; KETAMINE; KETOROLAC; LIDOCAINE; MIDAZOLAM; PARACETAMOL; RABIES IMMUNOGLOBULIN; RABIES VACCINE; RIBAVIRIN; SALBUTAMOL; ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE;

ACIDOSIS; ADOLESCENT; ANTIBODY PRODUCTION; ARTICLE; ATHETOSIS; BITE; CASE REPORT; CLINICAL FEATURE; COMA; DIPLOPIA; DISEASE COURSE; DYSARTHRIA; FATIGUE; FEMALE; GAIT; HEALTH CARE FACILITY; HEMOLYSIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; LIVER TOXICITY; LUMBAR PUNCTURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PARESIS; PARESTHESIA; PATIENT; PRIORITY JOURNAL; RABIES; SEDATION; SENSORY NERVE; SURVIVAL; TREATMENT OUTCOME; ANIMAL; BAT; BITES AND STINGS; CHEMICALLY INDUCED DISORDER; CHOREA; IMMUNOLOGY; NEUROLOGIC DISEASE; RABIES VIRUS;

ADOLESCENT; AMANTADINE; ANESTHETICS; ANIMALS; ANTIVIRAL AGENTS; ATHETOSIS; BENZODIAZEPINES; BITES AND STINGS; CHIROPTERA; CHOREA; COMA; DYSARTHRIA; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; KETAMINE; MIDAZOLAM; RABIES; RABIES VIRUS; RIBAVIRIN;

EID: 20444444376     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa050382     Document Type: Article

References (25)

1. Gode GR, Raju AV, Jayalakshmi TS, Kaul HL, Bhide NK. Intensive care in rabies therapy: clinical observations. Lancet 1976;2:6-8.
2. Emmons RW, Leonard LL, DeGenaro F Jr, et al. A case of human rabies with prolonged survival. Intervirology 1973;1:60-72.
3. Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis 2003;36:60-3.
4. Willoughby RE, Rotar MM, Dohnau HL, et al. Recovery of a patient from clinical rabies - Wisconsin, 2004. MMWR Morb Mortal Wkly Rep 2005;53:1171-3.
5. Hattwick MA, Weis TT, Stechschulte CJ, Baer GM, Gregg MB. Recovery from rabies: a case report. Ann Intern Med 1972;76:931-42.
6. Hoffman GM, Stuth EA, Jaquiss RD, et al. Changes in cerebral and somatic oxygenation during stage 1 palliation of hypoplastic left heart syndrome using continuous regional cerebral perfusion. J Thorac Cardiovasc Surg 2004;127:223-33.
7. Bhatt DR, Hattwick MA, Gerdsen R, Emmons RW, Johnson HN. Human rabies: diagnosis, complications, and management. Am J Dis Child 1974;127:862-9.
8. Mrak RE, Young L. Rabies encephalitis in humans: pathology, pathogenesis and pathophysiology. J Neuropathol Exp Neurol 1994;53:1-10.
9. Superti F, Seganti L, Pana A, Orsi N. Effect of amantadine on rhabdovirus infection. Drugs Exp Clin Res 1985;11:69-74.
10. Porter RH, Greenamyre JT. Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J Neurochem 1995;64:614-23.
11. Maton PN, Pollard JD, Davis JN. Human rabies encephalomyelitis. Br Med J 1976;1:1038-40.
12. Jogai S, Radotra BD, Banerjee AK. Rabies viral antigen in extracranial organs: a postmortem study. Neuropathol Appl Neurobiol 2002;28:334-8.
13. Jackson AC, Ye H, Phelan CC, et al. Extraneural organ involvement in human rabies. Lab Invest 1999;79:945-51.
14. Bell JF, Moore GJ. Effects of high ambient temperature on various stages of rabies virus infection in mice. Infect Immun 1974;10:510-5.
15. Rubin RH, Sullivan L, Summers R, Gregg MB, Sikes RK. A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. J Infect Dis 1970;122:318-22.
16. Lodmell DL, Bell JF, Moore GJ, Raymond GH. Comparative study of abortive and nonabortive rabies in mice. J Infect Dis 1969;119:569-80.
17. Jackson AC. Rabies virus infection: an update. J Neurovirol 2003;9:253-8.
18. Gode GR, Saksena R, Batra RK, Kalia PK, Bhide NK. Treatment of 54 clinically diagnosed rabies patients with two survivals. Indian J Med Res 1988;88:564-6.
19. Lockhart BP, Tordo N, Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob Agents Chemother 1992;36:1750-5.
20. Beilin B, Shavit Y, Razumovsky J, Wolloch Y, Zeidel A, Bessler H. Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology 1998;89:1133-40.
21. Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989;36:186-97.
22. Wang X, Shimizu-Sasamata M, Moskowitz MA, Newcomb R, Lo EH. Profiles of glutamate and GABA efflux in core versus peripheral zones of focal cerebral ischemia in mice. Neurosci Lett 2001;313:121-4.
23. Nargi-Aizenman JL, Havert MB, Zhang M, Irani DN, Rothstein JD, Griffin DE. Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann Neurol 2004;55:541-9.
24. Warrell DA, Davidson NM, Pope HM, et al. Pathophysiologic studies in human rabies. Am J Med 1976;60:180-90.
25. Fleischer R, Boxwell D, Sherman KE. Nucleoside analogues and mitochondrial toxicity. Clin Infect Dis 2004;38:e79-e80.